Bard Financial Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Bard Financial Services's BMY.RT Position: Q1 2021 in Review
Bard Financial Services sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 19,875 shares — an estimated $13.7M sold.
Bard Financial Services first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $13.7M in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Bard Financial Services reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Bard Financial Services sold 19,875 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $13.7M.
- Bard Financial Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
- Bard Financial Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $13.7M in Q4 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Bard Financial Services's 13F filing for Q1 2021, filed 14 May 2021.